Biogen CEO Michel Vounatsos told CNBC on Monday that the list price of $56,000 per year for the company’s FDA-approved Alzheimer’s disease drug aducanumab is “fair.” That being said, the Massachusetts-based biotech company has vowed to not increase the price of the medication, which is marketed under the name Aduhelm,Continue Reading

Вот самые важные новости, тенденции и анализ, которые нужны инвесторам для начала своего торгового дня: 1. Фондовые фьючерсы выросли после выхода небольшого отчета по занятости за май Трейдеры на Нью-Йоркской фондовой бирже. Источник: NYSE Президент США Джо Байден (слева) в защитной маске во время выступления во время встречи с сенаторомContinue Reading

Exmouth RNLI volunteer crew members launched their inshore lifeboat this evening following a report that two female paddleboarders in difficulty near Budleigh Salterton. At 7.16pm today Wednesday 26 May 2021 Exmouth RNLI inshore lifeboat D-805 George Bearman II was launched having been tasked by H.M. Coastguard to a report ofContinue Reading